Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic LeukemiaTait D. Shanafelt, Martin S. Tallman, Susan O’Brien et al.|New England Journal of Medicine|2019Cited by 735
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R. Litzow, Martin S. Tallman, Zhuoxin Sun et al.|New England Journal of Medicine|2024Cited by 213